KCFA
Key Client Fiduciary Advisors’s Leap Therapeutics LPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Sell |
343,862
-44,859
| -12% | -$13.3K | 0.04% | 199 |
|
|
2025
Q1 | $119K | Buy |
388,721
+27,468
| +8% | +$8.38K | 0.05% | 182 |
|
|
2024
Q4 | $1.04M | Buy |
361,253
+39,330
| +12% | +$113K | 0.46% | 50 |
|
|
2024
Q3 | $827K | Buy |
321,923
+37,067
| +13% | +$95.3K | 0.37% | 62 |
|
|
2024
Q2 | $558K | Buy |
284,856
+51,838
| +22% | +$102K | 0.28% | 83 |
|
|
2024
Q1 | $620K | Buy |
233,018
+18,408
| +9% | +$49K | 0.33% | 71 |
|
|
2023
Q4 | $890K | Sell |
214,610
-12,663
| -6% | -$52.5K | 0.52% | 42 |
|
|
2023
Q3 | $314K | Buy |
227,273
+68,676
| +43% | +$94.8K | 0.19% | 121 |
|
|
2023
Q2 | $496K | Sell |
158,597
-1,377,219
| -90% | -$4.31M | 0.29% | 81 |
|
|
2023
Q1 | $522K | Buy |
1,535,816
+186,495
| +14% | +$63.4K | 0.33% | 68 |
|
|
2022
Q4 | $607K | Buy |
1,349,321
+228,378
| +20% | +$103K | 0.41% | 54 |
|
|
2022
Q3 | $986K | Buy |
1,120,943
+61,242
| +6% | +$53.9K | 0.89% | 25 |
|
|
2022
Q2 | $1.22M | Buy |
1,059,701
+351,871
| +50% | +$405K | 1.19% | 22 |
|
|
2022
Q1 | $1.24M | Buy |
707,830
+198,850
| +39% | +$348K | 0.98% | 27 |
|
|
2021
Q4 | $1.65M | Buy |
+508,980
| New | +$1.65M | 1.36% | 20 |
|